Navigation Links
Simbionix Signs an Agreement with the Laparoscopic Surgical Skills Foundation (LSS)
Date:2/20/2013

CLEVELAND, Ohio, February 20, 2013 /PRNewswire/ --

Simbionix and the Laparoscopic Surgical Skills Foundation (LSS) signed a collaboration agreement that is supported by Europe's most prestigious society in the laparoscopic discipline, The European Association for Endoscopic Surgery (EAES).  Training materials and assessment tools for the European Laparoscopic Skills Curriculum will be the result of this initiative.

     (Logo: http://photos.prnewswire.com/prnh/20120502/529202-a)
Recent safety and surgical quality performance reports from the World Health Organization and others stress the urgent need for the improvement of training, assessment, and accreditation for technology-dependent surgical procedures such as laparoscopy. LSS is an initiative by the European Association for Endoscopic Surgery (EAES) to provide a standard to (re)credential surgeons to perform laparoscopic surgery effectively and safely. LSS goes beyond the basic skills and focuses on safeguarding the quality of performance in laparoscopic procedures.

This agreement is a continuation of successful two-year collaboration during which the LSS program has been operating in training centers across Europe.  This incorporates the Simbionix LAP Mentor in the process of defining and validating the criterion-based assessment tool and clinical assessment of index procedures performance.

Professor Jakimowicz, MD, PhD, FRCS Ed said, "This agreement shows the benefit of industry and professional society collaboration. The structure of the training, applicability of the course content in practice and the proportion of theory and hands-on training are rated positively by the trainees."  Prof. Jakimowicz added, "The LSS program appeals to both residents in training and already accredited surgeons. International participation indicates that the LSS program has the potential to become a future European standard in surgical education in laparoscopic surgery. "

Ran Bronstein, President of Simbionix, expressed excitement about the agreement: "As a leading provider of medical simulators and online medical education, Simbionix understands the importance of providing access to standardized training. This collaboration, by leveraging the clinical knowledge and experience of the EAES and the innovative technologies of Simbionix, will set a new standard for laparoscopic skills training in Europe."

About the LSS:
Laparoscopic Surgical Skills (LSS) program, developed under the auspices of the European Association for Endoscopic Surgery (EAES), aims to provide a standard to credential surgeons to perform laparoscopic surgery effectively and safely.

About Simbionix:

Simbionix is the world's leading provider of medical simulation training and education solutions for the healthcare industry. Visit: http://www.simbionix.com  

Contact: Susan Vetrone , North American Director of Marketing susanv@simbionix.com  Toll Free 866-SIMBIONIX or +1-216-229-2040, Fax +1-216-229-2070.



'/>"/>
SOURCE Simbionix Ltd.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Simbionix Releases Two New Platforms at the Upcoming DDW and AUA Events
2. MicroConstants China Signs Site Management Organization Agreement with the Clinical Research Center of No. 307 Hospital
3. SafeCode Drug Technologies Corp Signs an Agreement With INTOVISION PRODUCT DEVELOPMENT & DESIGN (An Israeli Product Development Co) to Manufacturers the Worlds First Voice Recognition Drug Safety Application Prototype
4. Joint Reconstruction (Hip and Knee Devices) Market to 2018 - Advanced Implant Materials, Innovative Designs and Improved Longevity lead to Rise in the Number of Early Joint Replacement Surgeries
5. UV Flu Technologies Signs a Distribution Agreement with DPG Distribution
6. Volcano Corporation Signs Agreement to Acquire Sync-Rx Ltd.
7. Reckitt Benckiser Signs Merger Agreement To Acquire Schiff Nutrition
8. Colorado Telehealth Network Signs Contract with GNAX Health to Provide Statewide Medical Image Archive and Exchange
9. Medisafe 1 Technologies Signs the $7MM Perpetual License Agreement
10. TNI BioTech, Inc. Signs Exclusive Distributor Agreement for Federal Republic of Nigeria with G-Ex Technologies/St. Maris Pharma & GB Pharma Holdings LLC
11. HealthTrust Purchasing Group Signs Renewal for GHX Solutions to Continue Supply Chain Cost Reductions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... HILLS, Calif. , June 23, 2016 Any ... the many challenges of the current process. Many of them ... because of the technical difficulties and high laboratory costs involved. ... have to offer it at such a high cost that ... afford it. Dr. Parsa Zadeh , founder ...
(Date:6/23/2016)... -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that ... PCT (procalcitonin) assay as a dedicated testing solution for ... clearance, Roche is the first IVD company in the ... risk assessment and management. PCT is a ... in blood can aid clinicians in assessing the risk ...
(Date:6/23/2016)... June 23, 2016 Research and Markets ... Issue 52" report to their offering. ... treatment creates a favourable commercial environment for MedImmune to enter. ... base that will serve to drive considerable growth for effective ... serve to cap sales considerably, but development is still in ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... Experts from the ... AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the Hynes Convention Center in ... topics including advance care planning, healthcare costs and patient and family engagement. , ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library ... City Observer , brings up a new, often overlooked aspect of head lice: the parasite’s ... for fumigation is not a common occurrence, but a necessary one in the event that ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room ... Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. ... of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. ... from injury. Recently, he has implemented orthobiologic procedures as a method for treating ... one of the first doctors to perform the treatment. Orthobiologics are substances that ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the ... In terms of the latter, setting the bar too high can result in disappointment, ... just slow progress toward their goal. , Research from PsychTests.com reveals ...
Breaking Medicine News(10 mins):